Your Source for Thailand's Medical, Health, Wellness, and Tourism Updates•Connecting You to Thailand's Vibrant Sectors, One Story at a Time
Thailand continues to captivate beach lovers from around the globe, and in 2025, it’s Bang Bao Beach on Koh Kood that has emerged as a star — officially ranked #3 in the world by The World’s 50 Best Beaches.
Read NewsThe Royal College of Ophthalmologists of Thailand has issued an official statement urging the public to exercise caution when consuming medical information shared on social media—particularly content that presents only the benefits of Refractive Lens Exchange (RLE) for correcting presbyopia (age-related farsightedness), without mentioning the potential risks and complications.
Read NewsMettapracharak Hospital (Wat Rai Khing), under the Department of Medical Services, has warned that corneal ulcers—a condition caused by inflammation or injury to the cornea—can result from several factors, including prolonged contact lens use, improper lens care, sleeping with lenses on, or excessive eye rubbing. People with dry eyes or allergies are also at higher risk. Additionally, small foreign particles like dust, sand, or metal can trigger inflammation and infection.
Read NewsLos Angeles, July 3 (Xinhua) — A new study published Wednesday (July 2) in the journal Nature reveals a strong connection between exposure to fine particulate air pollution (PM) and increased genetic mutations in lung tumors among people who have never smoked
Read NewsOn July 7, 2025, Chulalongkorn Hospital, under the Thai Red Cross Society, has become the first medical institution in Thailand—and the fourth in Asia—to successfully perform surgery for patients with Obstructive Sleep Apnea (OSA) using the latest hypoglossal nerve stimulation (HGNS) technique. This achievement reflects the hospital’s multidisciplinary collaboration, involving experts in sleep medicine, otolaryngology, internal medicine, nursing, and anesthesiology. The procedure offers a new treatment alternative for patients who cannot tolerate conventional therapy, helping to improve their overall quality of life.
Read NewsChulabhorn Royal Academy has officially announced the successful domestic production of “IMCRANIB 100,” Thailand’s first targeted cancer therapy developed and manufactured entirely within the country. This milestone reflects the strategic vision and dedication of Professor Dr. Her Royal Highness Princess Chulabhorn Krom Phra Srisavangavadhana in advancing national healthcare and pharmaceutical self-reliance.
Read News